Perri, F.; Longo, F.; Fusco, R.; D’Alessio, V.; Aversa, C.; Pavone, E.; Pontone, M.; Marciano, M.L.; Villano, S.; Franco, P.;
et al. Electrochemotherapy as a First Line Treatment in Recurrent Squamous Cell Carcinoma of the Oral Cavity and Oropharynx PDL-1 Negative and/or with Evident Contraindication to Immunotherapy: A Randomized Multicenter Controlled Trial. Cancers 2021, 13, 2210.
https://doi.org/10.3390/cancers13092210
AMA Style
Perri F, Longo F, Fusco R, D’Alessio V, Aversa C, Pavone E, Pontone M, Marciano ML, Villano S, Franco P,
et al. Electrochemotherapy as a First Line Treatment in Recurrent Squamous Cell Carcinoma of the Oral Cavity and Oropharynx PDL-1 Negative and/or with Evident Contraindication to Immunotherapy: A Randomized Multicenter Controlled Trial. Cancers. 2021; 13(9):2210.
https://doi.org/10.3390/cancers13092210
Chicago/Turabian Style
Perri, Francesco, Francesco Longo, Roberta Fusco, Valeria D’Alessio, Corrado Aversa, Ettore Pavone, Monica Pontone, Maria Luisa Marciano, Salvatore Villano, Pierluigi Franco,
and et al. 2021. "Electrochemotherapy as a First Line Treatment in Recurrent Squamous Cell Carcinoma of the Oral Cavity and Oropharynx PDL-1 Negative and/or with Evident Contraindication to Immunotherapy: A Randomized Multicenter Controlled Trial" Cancers 13, no. 9: 2210.
https://doi.org/10.3390/cancers13092210
APA Style
Perri, F., Longo, F., Fusco, R., D’Alessio, V., Aversa, C., Pavone, E., Pontone, M., Marciano, M. L., Villano, S., Franco, P., Togo, G., Fazio, G. R. D., Ordano, D., Maglitto, F., Salzano, G., Maglione, M. G., Guida, A., & Ionna, F.
(2021). Electrochemotherapy as a First Line Treatment in Recurrent Squamous Cell Carcinoma of the Oral Cavity and Oropharynx PDL-1 Negative and/or with Evident Contraindication to Immunotherapy: A Randomized Multicenter Controlled Trial. Cancers, 13(9), 2210.
https://doi.org/10.3390/cancers13092210